370 related articles for article (PubMed ID: 15813645)
1. Social functioning: should it become an endpoint in trials of antidepressants?
Bech P
CNS Drugs; 2005; 19(4):313-24. PubMed ID: 15813645
[TBL] [Abstract][Full Text] [Related]
2. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
3. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416
[TBL] [Abstract][Full Text] [Related]
4. Toward a very brief quality of life enjoyment and Satisfaction Questionnaire.
Rush AJ; South CC; Jha MK; Grannemann BD; Trivedi MH
J Affect Disord; 2019 Jan; 242():87-95. PubMed ID: 30173063
[TBL] [Abstract][Full Text] [Related]
5. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.
Trivedi MH; Dunner DL; Kornstein SG; Thase ME; Zajecka JM; Rothschild AJ; Friedman ES; Shelton RC; Keller MB; Kocsis JH; Gelenberg A
J Affect Disord; 2010 Nov; 126(3):420-9. PubMed ID: 20510459
[TBL] [Abstract][Full Text] [Related]
7. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
Demyttenaere K; Andersen HF; Reines EH
Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
[TBL] [Abstract][Full Text] [Related]
8. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.
Morton E; Bhat V; Giacobbe P; Lou W; Michalak EE; McInerney S; Chakrabarty T; Frey BN; Milev RV; Müller DJ; Parikh SV; Rotzinger S; Kennedy SH; Lam RW;
CNS Drugs; 2021 Apr; 35(4):439-450. PubMed ID: 33860922
[TBL] [Abstract][Full Text] [Related]
10. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
Pollack MH; Endicott J; Liebowitz M; Russell J; Detke M; Spann M; Ball S; Swindle R
J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755
[TBL] [Abstract][Full Text] [Related]
11. [Changes and Prediction of Social Functional Disability and Quality of Life in Patients with Major Depressive Disorder over the Course of 1-Year Medication].
Wang JY; Yuan ML; Zhang W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):904-910. PubMed ID: 36224695
[TBL] [Abstract][Full Text] [Related]
12. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.
Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P
J Clin Psychiatry; 2001; 62 Suppl 22():34-7. PubMed ID: 11599646
[TBL] [Abstract][Full Text] [Related]
13. Assessment of quality of life enjoyment and satisfaction questionnaire-short form responder thresholds in generalized anxiety disorder and bipolar disorder studies.
Wyrwich KW; Harnam N; Revicki DA; Locklear JC; Svedsater H; Endicott J
Int Clin Psychopharmacol; 2011 May; 26(3):121-9. PubMed ID: 21164351
[TBL] [Abstract][Full Text] [Related]
14. Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions - Improvement (CGI-S) scale in bipolar and major depressive disorder.
Mohebbi M; Dodd S; Dean OM; Berk M
Eur Psychiatry; 2018 Sep; 53():17-22. PubMed ID: 29859377
[TBL] [Abstract][Full Text] [Related]
15. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.
Lee Y; Rosenblat JD; Lee J; Carmona NE; Subramaniapillai M; Shekotikhina M; Mansur RB; Brietzke E; Lee JH; Ho RC; Yim SJ; McIntyre RS
J Affect Disord; 2018 Feb; 227():406-415. PubMed ID: 29154157
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
18. Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale.
Sheehan KH; Sheehan DV
Int Clin Psychopharmacol; 2008 Mar; 23(2):70-83. PubMed ID: 18301121
[TBL] [Abstract][Full Text] [Related]
19. Comparison of quality of life measures in a depressed population.
Wisniewski SR; Rush AJ; Bryan C; Shelton R; Trivedi MH; Marcus S; Husain MM; Hollon SD; Fava M;
J Nerv Ment Dis; 2007 Mar; 195(3):219-25. PubMed ID: 17468681
[TBL] [Abstract][Full Text] [Related]
20. Validity and reliability of the Chinese version of the Short Form of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-SF).
Lee YT; Liu SI; Huang HC; Sun FJ; Huang CR; Yeung A
Qual Life Res; 2014 Apr; 23(3):907-16. PubMed ID: 24062242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
